Offer An Article

Pandemic Latest News

Bharat Biotech

Covaxin to face WHO scrutiny this week

India’s homegrown COVID-19 vaccine Covaxin is to face scrutiny from the World Health Organization (WHO) on June 23rd when a pre-submission hearing will be held.  Manufacturer Bharat Biotech received the WHO’s nod for its expression of interest for emergency use listing of Covaxin, in a step commentators regard as moving the vaccine closer to securing […]

Covaxin to face WHO scrutiny this week Read More »

Covaxin trials to start among minors

Trials of Covaxin, India’s indigenously-manufactured COVID-19 vaccine candidate, are set to begin among young people to test its immunogenicity, reactogenicity, and safety. Trials among those aged between twelve and eighteen years are set to commence across five institutes throughout India. The institutes in question are the All India Institute of Medical Sciences (AIIMS) in Bihar

Covaxin trials to start among minors Read More »